{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:50:38Z","timestamp":1788929438802,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T00:00:00Z","timestamp":1392163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"crossref","award":["00023001"],"award-info":[{"award-number":["00023001"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"crossref","award":["304\/12\/0259"],"award-info":[{"award-number":["304\/12\/0259"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Internal Grant Agency of the Ministry of Health","award":["NT\/12171-5"],"award-info":[{"award-number":["NT\/12171-5"]}]},{"name":"Internal Grant Agency of the Ministry of Health","award":["NT\/14012-3"],"award-info":[{"award-number":["NT\/14012-3"]}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["CZ.2.16\/3.1.00\/22126"],"award-info":[{"award-number":["CZ.2.16\/3.1.00\/22126"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.lfs.2013.12.018","type":"journal-article","created":{"date-parts":[[2013,12,25]],"date-time":"2013-12-25T05:45:18Z","timestamp":1387950318000},"page":"297-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Addition of ETA receptor blockade increases renoprotection provided by renin\u2013angiotensin system blockade in 5\/6 nephrectomized Ren-2 transgenic rats"],"prefix":"10.1016","volume":"118","author":[{"given":"V\u011bra","family":"\u010cert\u00edkov\u00e1 Ch\u00e1bov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenka","family":"Vernerov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Kujal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Huskov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"\u0160karoupkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladim\u00edr","family":"Tesa\u0159","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert J.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elzbieta","family":"Kompanowska-Jezierska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Walkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Sadowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lud\u011bk","family":"\u010cervenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Van\u011b\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2013.12.018_bb0230","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1006\/bbrc.1997.7394","article-title":"Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation","volume":"238","author":"Barton","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.lfs.2013.12.018_bb0130","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ki.1993.263","article-title":"A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression","volume":"44","author":"Benigni","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.lfs.2013.12.018_bb0235","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1681\/ASN.2010020193","article-title":"ETA activation mediates angiotensin II-induced infiltration of renal cortical T cells","volume":"22","author":"Boesen","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lfs.2013.12.018_bb0010","first-page":"F324","article-title":"Nephron adaptation to renal injury or ablation","volume":"249","author":"Brenner","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1016\/j.lfs.2013.12.018_bb0110","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1042\/CS20120074","article-title":"Chronic kidney disease and vascular remodeling: molecular mechanisms and clinical implications","volume":"123","author":"Briet","year":"2012","journal-title":"Clin Sci"},{"key":"10.1016\/j.lfs.2013.12.018_bb0125","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/ndt\/14.8.1881","article-title":"Endothelin ETA receptor blockade prevents the progression of renal failure and hypertension in uraemic rats","volume":"14","author":"Brochu","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lfs.2013.12.018_bb0095","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1161\/01.HYP.36.4.561","article-title":"Blockade of the renin\u2013angiotensin and endothelin systems on progressive renal injury","volume":"36","author":"Cao","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2013.12.018_bb0215","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1042\/CS20090459","article-title":"Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats","volume":"118","author":"\u010cert\u00edkov\u00e1 Ch\u00e1bov\u00e1","year":"2010","journal-title":"Clin Sci"},{"key":"10.1016\/j.lfs.2013.12.018_bb0185","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/HJH.0b013e3282fe6eaa","article-title":"Pivotal role of AT1A receptors in the development of two-kidney, one-clip hypertension: study in AT1A receptor knockout mice","volume":"26","author":"\u010cervenka","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.lfs.2013.12.018_bb0170","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/j.1523-1755.2005.00290.x","article-title":"An extremely high dose of losartan affords superior renoprotection in the remnant model","volume":"67","author":"Fujihara","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.lfs.2013.12.018_bb0240","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1172\/JCI65460","article-title":"The absence of intrarenal ACE protects against hypertension","volume":"125","author":"Gonzalez-Villalobos","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lfs.2013.12.018_bb0065","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1053\/j.ackd.2011.06.002","article-title":"Off the beaten renin\u2013angiotensin\u2013aldosterone system pathway: new perspectives on antiproteinuric therapy","volume":"18","author":"Gordon","year":"2011","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.lfs.2013.12.018_bb0195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/HJH.0b013e32835b50aa","article-title":"Antihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAME","volume":"31","author":"Honetschlagerov\u00e1","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.lfs.2013.12.018_bb0020","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/snep.2003.50017","article-title":"Hyperfiltration and glomerulosclerosis","volume":"23","author":"Hostetter","year":"2003","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.lfs.2013.12.018_bb0180","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000092981","article-title":"Effects of anesthesia on plasma and kidney ANG II levels in normotensive and ANG II-dependent hypertensive rats","volume":"29","author":"Huskova","year":"2006","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.lfs.2013.12.018_bb0190","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/HJH.0b013e3283345d69","article-title":"Inappropriately high circulating and intrarenal angiotensin II levels during dietary salt loading exacerbate hypertension in Cyp1a1-Ren-2 transgenic rats","volume":"28","author":"Huskov\u00e1","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.lfs.2013.12.018_bb0080","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1097\/HJH.0b013e32833097bb","article-title":"Effect of pravastatin on nephroprotection in deoxycosterone acetate-salt hypertensive rats","volume":"27","author":"Kang","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.lfs.2013.12.018_bb0250","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.ph.57.030195.001431","article-title":"Transforming growth factor-\u03b2 and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis?","volume":"57","author":"Ketteler","year":"1995","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.lfs.2013.12.018_bb0225","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/pr.59.3.3","article-title":"The intrarenal renin\u2013angiotensin system: from physiology to the pathobiology of hypertension and kidney disease","volume":"59","author":"Kobori","year":"2007","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.lfs.2013.12.018_bb0105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/MNH.0b013e328335f91f","article-title":"Endothelin, hypertension and chronic kidney disease: new insight","volume":"19","author":"Kohan","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.lfs.2013.12.018_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00060.2009","article-title":"Regulation of blood pressure and salt homeostasis by endothelin","volume":"91","author":"Kohan","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.lfs.2013.12.018_bb0155","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1440-1681.2010.05453.x","article-title":"Similar renoprotection after renin\u2013angiotensin-dependent and -independent antihypertensive therapy in 5\/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?","volume":"37","author":"Kujal","year":"2010","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.lfs.2013.12.018_bb0175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1161\/01.HYP.0000150857.39919.cb","article-title":"Recommendations for blood pressure measurements in humans and experimental animals. Part 2: blood pressure measurements in experimental animals","volume":"45","author":"Kurtz","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2013.12.018_bb0210","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/ki.1992.165","article-title":"Estimation of glomerular volume: a comparison of four methods","volume":"41","author":"Lane","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.lfs.2013.12.018_bb0055","first-page":"655","article-title":"Targeting the renin angiotensin system for remission\/regression of chronic kidney disease","volume":"25","author":"Macconi","year":"2010","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.lfs.2013.12.018_bb0035","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"Guidelines for the Management of Arterial Hypertension. The task force of the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.lfs.2013.12.018_bb0120","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/344541a0","article-title":"Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene","volume":"344","author":"Mullins","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2013.12.018_bb0060","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1681\/ASN.V541139","article-title":"Evidence that an angiotensin-converting enzyme inhibitor has a different effect on glomerular injury according to the different phase of the disease at which the treatment is started","volume":"5","author":"Perico","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lfs.2013.12.018_bb0140","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1681\/ASN.V871054","article-title":"ETA receptor blockade prevents hypertension associated with exogenous endothelin-1 but not renal mass reduction in the rat","volume":"8","author":"Pollock","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lfs.2013.12.018_bb0135","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1161\/01.HYP.30.6.1578","article-title":"Role of endothelin in hypertension of experimental chronic renal failure","volume":"30","author":"Potter","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2013.12.018_bb0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/hr.2012.157","article-title":"The effect of antihypertensive drugs on chronic kidney disease: a comprehensive review","volume":"36","author":"Ptinopolou","year":"2013","journal-title":"Hypertens Res"},{"key":"10.1016\/j.lfs.2013.12.018_bb0090","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0008-6363(99)00110-8","article-title":"Interactions between endothelin-1 and renin\u2013angiotensin\u2013aldosterone system","volume":"43","author":"Rossi","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.lfs.2013.12.018_bb0050","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1681\/ASN.2006040356","article-title":"Renin\u2013angiotensin\u2013aldosterone system and progression of renal disease","volume":"17","author":"R\u00fcster","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.lfs.2013.12.018_bb0205","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/ki.1987.262","article-title":"The enhancement of aminonucleoside nephrosis by the co-administration of protamine","volume":"32","author":"Saito","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.lfs.2013.12.018_bb0085","first-page":"R243","article-title":"Renal endothelin in chronic angiotensin II hypertension","volume":"283","author":"Sasser","year":"2002","journal-title":"Am J Physiol"},{"key":"10.1016\/j.lfs.2013.12.018_bb0045","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ki.2011.380","article-title":"Treatment of chronic kidney disease","volume":"81","author":"Turner","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.lfs.2013.12.018_bb0005","series-title":"Annual data report: Atlas of chronic kidney disease and end-stage renal disease in the United States","author":"U.S. Renal Data System: USEDS","year":"2012"},{"key":"10.1016\/j.lfs.2013.12.018_bb0025","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-154-8-201104190-00335","article-title":"Systemic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier","volume":"154","author":"Upadhyay","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lfs.2013.12.018_bb0075","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/01.HYP.0000173426.06832.b5","article-title":"Early endothelin-A receptor blockade decreases blood pressure and ameliorates end-organ damage in homozygous Ren-2 rats","volume":"46","author":"Van\u011b\u010dkov\u00e1","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2013.12.018_bb0115","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1159\/000336823","article-title":"Effects of combined endothelin A receptor and renin\u2013angiotensin system blockade on the course of end-organ damage in 5\/6 nephrectomized Ren-2 hypertensive rats","volume":"35","author":"Van\u011b\u010dkov\u00e1","year":"2012","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.lfs.2013.12.018_bb0200","doi-asserted-by":"crossref","first-page":"339","DOI":"10.33549\/physiolres.931900","article-title":"Despite similar reduction of blood pressure and renal ANG II and ET-1 levels aliskiren but not losartan normalizes albuminuria in hypertensive Ren-2 rats","volume":"59","author":"Va\u0148ourkov\u00e1","year":"2010","journal-title":"Physiol Res"},{"issue":"Suppl. 2","key":"10.1016\/j.lfs.2013.12.018_bb0100","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.33549\/physiolres.931640","article-title":"End-organ damage in hypertensive transgenic Ren-2 rats: influence of early and late endothelin receptor blockade","volume":"58","author":"Vernerov\u00e1","year":"2009","journal-title":"Physiol Res"},{"key":"10.1016\/j.lfs.2013.12.018_bb0030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ki.2012.425","article-title":"Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease?","volume":"83","author":"Wheeler","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.lfs.2013.12.018_bb0245","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1291\/hypres.27.493","article-title":"Olmesartan improves endothelin-induced hypertension and oxidative stress in rats","volume":"27","author":"Yao","year":"2004","journal-title":"Hypertens Res"},{"key":"10.1016\/j.lfs.2013.12.018_bb0145","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ki.1989.35","article-title":"Glomerular hemodynamic changes vs. Hypertrophy in experimental glomerular sclerosis","volume":"35","author":"Yoshida","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.lfs.2013.12.018_bb0150","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/ki.1989.239","article-title":"Effects of antihypertensive drugs on glomerular morphology","volume":"36","author":"Yoshida","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.lfs.2013.12.018_bb0015","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.mnh.0000222691.53970.83","article-title":"Progression of chronic kidney disease: insight from animal models","volume":"15","author":"Zoja","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320513007753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320513007753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:15:24Z","timestamp":1758399324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320513007753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0024320513007753"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2013.12.018","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Addition of ETA receptor blockade increases renoprotection provided by renin\u2013angiotensin system blockade in 5\/6 nephrectomized Ren-2 transgenic rats","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2013.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}